# Study to Assess the Efficacy, Safety and Tolerability of (iTind)

> **NCT03239951** · NA · TERMINATED · sponsor: **Medi-Tate Ltd.** · enrollment: 5 (actual)

## Conditions studied

- BPH

## Interventions

- **DEVICE:** iTind

## Key facts

- **NCT ID:** NCT03239951
- **Lead sponsor:** Medi-Tate Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-27
- **Primary completion:** 2020-01-20
- **Final completion:** 2020-03-31
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Due to the COVID-19 outbreak and the overall low recruitment
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03239951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03239951, "Study to Assess the Efficacy, Safety and Tolerability of (iTind)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03239951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*